Adiponectin acts in the nucleus of the solitary tract to decrease blood pressure by modulating the excitability of neuropeptide Y neurons

Brain Research

Volumn 1256, Issue , 2009, Pages 76-84

  Hoyda, Ted D ^a   Smith, Pauline M ^a   Ferguson, Alastair V ^a  

^a QUEEN S UNIVERSITY   (Canada)

Author keywords

Adiponectin; Electrophysiology; GABA; Hypotension; NPY; ssRT PCR

Indexed keywords

ADIPONECTIN RECEPTOR 1; ADIPONECTIN RECEPTOR 2; GLUTAMATE DECARBOXYLASE 67; NEUROPEPTIDE Y;

ANIMAL TISSUE; ARTICLE; BLOOD PRESSURE MEASUREMENT; CELL FUNCTION; CONTROLLED STUDY; ENZYME ACTIVATION; HEART RATE; HYPERTENSION; IN VIVO STUDY; MALE; NERVE CELL MEMBRANE POTENTIAL; NERVE EXCITABILITY; NONHUMAN; PRIORITY JOURNAL; RAT; SOLITARY TRACT NUCLEUS;

ADIPONECTIN; ANIMALS; BLOOD PRESSURE; CARDIOVASCULAR AGENTS; GENE EXPRESSION; GLUTAMATE DECARBOXYLASE; HEART RATE; MALE; MEMBRANE POTENTIALS; MICROINJECTIONS; NEURONS; NEUROPEPTIDE Y; PATCH-CLAMP TECHNIQUES; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, ADIPONECTIN; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SOLITARY NUCLEUS;

EID: 59649099952     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brainres.2008.12.012     Document Type: Article

References (36)

1. Ahima R.S., and Lazar M.A. Adipokines and the peripheral and neural control of energy balance. Mol. Endocrinol. 22 (2008) 1023-1031
2. Catelli J.M., Giakas W.J., and Sved A.F. GABAergic mechanisms in nucleus tractus solitarius alter blood pressure and vasopressin release. Brain Res. 403 (1987) 279-289
3. Dunbar J.C., Ergene E., Anderson G.F., and Barraco R.A. Decreased cardiorespiratory effects of neuropeptide Y in the nucleus tractus solitarius in diabetes. Am. J. Physiol. 262 (1992) R865-R871
4. Ergene E., Dunbar J.C., and Barraco R.A. Visceroendocrine responses elicited by neuropeptide Y in the nucleus tractus solitarius. Brain Res. Bull. 32 (1993) 461-465
5. Fry M., Smith P.M., Hoyda T.D., Duncan M., Ahima R.S., Sharkey K.A., and Ferguson A.V. Area postrema neurons are modulated by the adipocyte hormone adiponectin. J. Neurosci. 26 (2006) 9695-9702
6. Furuhashi M., Ura N., Higashiura K., Murakami H., Tanaka M., Moniwa N., Yoshida D., and Shimamoto K. Blockade of the renin-angiotensin system increases adiponectin concentrations in patients with essential hypertension. Hypertension 42 (2003) 76-81
7. Guyenet P.G. The sympathetic control of blood pressure. Nat. Rev. Neurosci. 7 (2006) 335-346
8. Hara K., Boutin P., Mori Y., Tobe K., Dina C., Yasuda K., Yamauchi T., Otabe S., Okada T., Eto K., Kadowaki H., Hagura R., Akanuma Y., Yazaki Y., Nagai R., Taniyama M., Matsubara K., Yoda M., Nakano Y., Tomita M., Kimura S., Ito C., Froguel P., and Kadowaki T. Genetic variation in the gene encoding adiponectin is associated with an increased risk of type 2 diabetes in the Japanese population. Diabetes 51 (2002) 536-540
9. Hoyda T.D., Fry M., Ahima R.S., and Ferguson A.V. Adiponectin selectively inhibits oxytocin neurons of the paraventricular nucleus of the hypothalamus. J. Physiol. 585 (2007) 805-816
10. Iwashima Y., Katsuya T., Ishikawa K., Ouchi N., Ohishi M., Sugimoto K., Fu Y., Motone M., Yamamoto K., Matsuo A., Ohashi K., Kihara S., Funahashi T., Rakugi H., Matsuzawa Y., and Ogihara T. Hypoadiponectinemia is an independent risk factor for hypertension. Hypertension 43 (2004) 1318-1323
11. Kadowaki T., and Yamauchi T. Adiponectin and adiponectin receptors. Endocr. Rev. 26 (2005) 439-451
12. Kos K., Harte A.L., da Silva N.F., Tonchev A., Chaldakov G., James S., Snead D.R., Hoggart B., O'Hare J.P., McTernan P.G., and Kumar S. Adiponectin and resistin in human cerebrospinal fluid and expression of adiponectin receptors in the human hypothalamus. J. Clin. Endocrinol. Metab. 92 (2007) 1129-1136
13. Kubo T., and Kihara M. Modulation of the aortic baroreceptor reflex by neuropeptide Y, neurotensin and vasopressin microinjected into the nucleus tractus solitarii of the rat. Naunyn Schmiedebergs Arch. Pharmacol. 342 (1990) 182-188
14. Kubota N., Yano W., Kubota T., Yamauchi T., Itoh S., Kumagai H., Kozono H., Takamoto I., Okamoto S., Shiuchi T., Suzuki R., Satoh H., Tsuchida A., Moroi M., Sugi K., Noda T., Ebinuma H., Ueta Y., Kondo T., Araki E., Ezaki O., Nagai R., Tobe K., Terauchi Y., Ueki K., Minokoshi Y., and Kadowaki T. Adiponectin stimulates AMP-activated protein kinase in the hypothalamus and increases food intake. Cell Metab. 6 (2007) 55-68
15. Kusminski C.M., McTernan P.G., Schraw T., Kos K., O'Hare J.P., Ahima R., Kumar S., and Scherer P.E. Adiponectin complexes in human cerebrospinal fluid: distinct complex distribution from serum. Diabetologia 50 (2007) 634-642
16. Lawrence A.J., and Jarrott B. Neurochemical modulation of cardiovascular control in the nucleus tractus solitarius. Prog. Neurobiol. 48 (1996) 21-53
17. Lawrence A.J., Castillo-Melendez M., McLean K.J., and Jarrott B. The distribution of nitric oxide synthase-, adenosine deaminase- and neuropeptide Y-immunoreactivity through the entire rat nucleus tractus solitarius: effect of unilateral nodose ganglionectomy. J. Chem. Neuroanat. 15 (1998) 27-40
18. McLean H.A., Champagnat J., and avit-Saubie M. A cholecystokinin-B receptor antagonist potentiates GABAergic and glycinergic inhibition in the nucleus of the solitary tract of the rat. Eur. J. Neurosci. 8 (1996) 1078-1084
19. Ohashi K., Kihara S., Ouchi N., Kumada M., Fujita K., Hiuge A., Hibuse T., Ryo M., Nishizawa H., Maeda N., Maeda K., Shibata R., Walsh K., Funahashi T., and Shimomura I. Adiponectin replenishment ameliorates obesity-related hypertension. Hypertension 47 (2006) 1108-1116
20. Paquet L., Massie B., and Mains R.E. Proneuropeptide Y processing in large dense-core vesicles: manipulation of prohormone convertase expression in sympathetic neurons using adenoviruses. J. Neurosci. 16 (1996) 964-973
21. Price C.J., Hoyda T.D., and Ferguson A.V. The area postrema: a brain monitor and integrator of systemic autonomic state. Neuroscientist 14 (2008) 182-194
22. Price C.J., Hoyda T.D., Samson W.K., and Ferguson A.V. Nesfatin-1 influences the excitability of paraventricular nucleus neurones. J. Neuroendocrinol. 20 (2008) 245-250
23. Qi Y., Takahashi N., Hileman S.M., Patel H.R., Berg A.H., Pajvani U.B., Scherer P.E., and Ahima R.S. Adiponectin acts in the brain to decrease body weight. Nat. Med. 10 (2004) 524-529
24. Saper C.B. The central autonomic nervous system: conscious visceral perception and autonomic pattern generation. Annu. Rev. Neurosci. 25 (2002) 433-469
25. Scherer P.E. Adipose tissue: from lipid storage compartment to endocrine organ. Diabetes 55 (2006) 1537-1545
26. Spranger J., Verma S., Gohring I., Bobbert T., Seifert J., Sindler A.L., Pfeiffer A., Hileman S.M., Tschop M., and Banks W.A. Adiponectin does not cross the blood-brain barrier but modifies cytokine expression of brain endothelial cells. Diabetes 55 (2006) 141-147
27. Tan K.C., Xu A., Chow W.S., Lam M.C., Ai V.H., Tam S.C., and Lam K.S. Hypoadiponectinemia is associated with impaired endothelium-dependent vasodilation. J. Clin. Endocrinol. Metab. 89 (2004) 765-769
28. Tanida M., Shen J., Horii Y., Matsuda M., Kihara S., Funahashi T., Shimomura I., Sawai H., Fukuda Y., Matsuzawa Y., and Nagai K. Effects of adiponectin on the renal sympathetic nerve activity and blood pressure in rats. Exp. Biol. Med. (Maywood) 232 (2007) 390-397
29. Tseng C.J., Mosqueda-Garcia R., Appalsamy M., and Robertson D. Cardiovascular effects of neuropeptide Y in rat brainstem nuclei. Circ. Res. 64 (1989) 55-61
30. Vincent A., and Tell F. Postnatal changes in electrophysiological properties of rat nucleus tractus solitarii neurons. Eur. J. Neurosci. 9 (1997) 1612-1624
31. Wang Z.V., and Scherer P.E. Adiponectin, cardiovascular function, and hypertension. Hypertension 51 (2008) 8-14
32. Wen J.P., Lv W.S., Yang J., Nie A.F., Cheng X.B., Yang Y., Ge Y., Li X.Y., and Ning G. Globular adiponectin inhibits GnRH secretion from GT1-7 hypothalamic GnRH neurons by induction of hyperpolarization of membrane potential. Biochem. Biophys. Res. Commun. 371 (2008) 756-761
33. Williams D.L., Baskin D.G., and Schwartz M.W. Leptin regulation of the anorexic response to glucagon-like Peptide-1 receptor stimulation. Diabetes 55 (2006) 3387-3393
34. Wyatt C.N., Mustard K.J., Pearson S.A., Dallas M.L., Atkinson L., Kumar P., Peers C., Hardie D.G., and Evans A.M. AMP-activated protein kinase mediates carotid body excitation by hypoxia. J. Biol. Chem. 282 (2007) 8092-8098
35. Yamauchi T., Kamon J., Ito Y., Tsuchida A., Yokomizo T., Kita S., Sugiyama T., Miyagishi M., Hara K., Tsunoda M., Murakami K., Ohteki T., Uchida S., Takekawa S., Waki H., Tsuno N.H., Shibata Y., Terauchi Y., Froguel P., Tobe K., Koyasu S., Taira K., Kitamura T., Shimizu T., Nagai R., and Kadowaki T. Cloning of adiponectin receptors that mediate antidiabetic metabolic effects. Nature 423 (2003) 762-769
36. Yang B., Brown K.K., Chen L., Carrick K.M., Clifton L.G., McNulty J.A., Winegar D.A., Strum J.C., Stimpson S.A., and Pahel G.L. Serum adiponectin as a biomarker for in vivo PPARgamma activation and PPARgamma agonist-induced efficacy on insulin sensitization/lipid lowering in rats. BMC Pharmacol. 4 (2004) 23